Corrigendum to "A novel mechanism of inhibiting in-stent restenosis with arsenic trioxide drug-eluting stent: Enhancing contractile phenotype of vascular smooth muscle cells via YAP pathway" [Bioact. Mater. 6 2 (February 2021) 375-385]

Bioact Mater. 2021 Aug 2:8:574. doi: 10.1016/j.bioactmat.2021.07.032. eCollection 2022 Feb.

¹ Laboratory of Tissue and Cell Biology, Lab Teaching & Management Center, Chongqing Medical University, Chongqing, 400016, China.
² Key Laboratory for Biorheological Science and Technology of Ministry of Education, State and Local Joint Engineering Laboratory for Vascular Implants, Bioengineering College of Chongqing University, Chongqing, 400030, China.
³ Beijing Amsinomed Medical Co., Ltd, Beijing, 100021, China.
⁴ Medical School, Newcastle University, Newcastle Upon Tyne, NE2 4AX, UK.
⁵ National Engineering Research Center for Biomaterials, Sichuan University, Chengdu, 610065, China.

Abstract

[This corrects the article DOI: 10.1016/j.bioactmat.2020.08.018.].